Blog

Peep How This Wealth Advising App Strives For Equitable Financial Futures

September 21, 2023

Mical Jeanlys-White intends to revolutionize investing by creating an equitable future for the finance world. In August 2023, Jeanlys-White launched a tech-centered investing and planning service company called WealthMore. According to Forbes, Jeanlys-White learned valuable lessons from her grandmother, her Haitian-American family’s financial planner. Although her grandmother did not have formal training in financial planning, she used […]

Read More

This Haitian-American Founder Launched A Wealth Advising App To Make Financial Freedom A Reality For All

September 21, 2023

Mical Jeanlys-White’s grandmother was the family’s financial planner. She didn’t have any formal planning education, but she knew enough to understand the importance of saving. The matriarch taught her Haitian-American granddaughter to live below her means and would often tell her adages like, spend money as slowly as you make it. Sage counsel, but, according to […]

Read More

Astarte Medical And Tiny Health Join Forces To Optimize Gut Health For Vulnerable Preterm Infants

September 21, 2023

The new partnership will seek to develop an end-to-end NICU solution to stratify and treat at-risk babies. Astarte Medical, a leading pediatric clinical intelligence company, is forming a joint venture with Tiny Health, makers of gut microbiome tests for babies and expecting parents. The partners have agreed to develop a clinical-facing technology solution to support gut […]

Read More

Von Seldeneck: Philadelphia must embrace change, collaboration to unlock full potential

September 21, 2023

Philadelphia has always been a city of firsts, from the first public library to the first zoo. Now, it’s time for us to add another feather to our cap with the first female mayor. As Cherelle Parker breaks through glass ceilings, she brings with her a fresh perspective and a determination to create a culture […]

Read More

Nobias Therapeutics Announces Acceptance Of Late-Breaking Abstract

September 20, 2023

Nobias Therapeutics, a biotechnology company pioneering AI-based deep phenotyping techniques to discover advanced therapeutics, today announced new results. From a Phase 2 clinical trial of NB-001 (fasoracetam) for the treatment of the neuropsychiatric symptoms associated with 22q11.2 deletion syndrome (“22q11DS”) in children have been selected for a poster presentation at the 52nd Child Neurology Society […]

Read More

Previous Next